Skip to main content
How strong is your knowledge on continuous glucose monitors? Take the quiz to test your expertise!
>
HIV Management
Resource Center
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
COVID-19
Danon Disease
Depression Care 360
Diabetes
Diabetes Technology
Digital Health Solutions in Diabetes
Dry Eye Disease
Endometrial Cancer
HIV Management
IgG4-Related Disease
Lupus Nephritis
MASH
Pain Management
Type 2 Diabetes
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
COVID-19
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Uterine Polyps
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Get Permissions
Search
Contact
Login
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
COVID-19
Danon Disease
Depression Care 360
Diabetes
Diabetes Technology
Digital Health Solutions in Diabetes
Dry Eye Disease
Endometrial Cancer
HIV Management
IgG4-Related Disease
Lupus Nephritis
MASH
Pain Management
Type 2 Diabetes
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
COVID-19
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Uterine Polyps
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Get Permissions
prevention
POP QUIZ: ASCVD Prevention in Patients With HIV
Copied to clipboard
<section><h2><p>What do current guidelines say about prescribing statins for the prevention of ASCVD in patients with HIV?</p></h2></section><section><h2><p>What do current guidelines say about prescribing statins for the prevention of ASCVD in patients with HIV?</p></h2></section><section><h2><p>Better luck next time</p></h2><p><p>The 2013 ACC/AHA guideline for preventing ASCVD states:</p><p><br></p><p>"The Expert Panel found extensive and consistent evidence supporting the use of statins for the prevention of ASCVD in many higher-risk primary- and all secondary-prevention individuals," in its section on Heart Failure.</p><p><br></p><p>"A high level of evidence supports the use of moderate-intensity statin therapy in persons who are 40 to 75 years of age," in its section on Diabetes.</p><p><br></p><p>"The evidence-based recommendations focus on patient groups who are well represented in RCTs and/or are highly likely to have high-risk genetic conditions, so the recommendations are designed to inform rather than replace clinical judgment," in its section on Limitations.</p><p><br></p><p><span style="color: black;">For more content, visit the </span><a href="https://www.consultant360.com/infectious-diseases" target="_blank" style="color: black;">Specialty Site</a><span style="color: black;">.</span></p></p></section><section><h3><p>Good job!</p></h3><p><p>The 2013 ACC/AHA guideline for preventing ASCVD states:</p><p><br></p><p>"The Expert Panel found extensive and consistent evidence supporting the use of statins for the prevention of ASCVD in many higher-risk primary- and all secondary-prevention individuals," in its section on Heart Failure.</p><p><br></p><p>"A high level of evidence supports the use of moderate-intensity statin therapy in persons who are 40 to 75 years of age," in its section on Diabetes.</p><p><br></p><p>"The evidence-based recommendations focus on patient groups who are well represented in RCTs and/or are highly likely to have high-risk genetic conditions, so the recommendations are designed to inform rather than replace clinical judgment," in its section on Limitations.</p><p><br></p><p><span style="color: black;">For more content, visit the </span><a href="https://www.consultant360.com/infectious-diseases" target="_blank" style="color: black;">Specialty Site</a><span style="color: black;">.</span></p></p></section>
